Compare SPCE & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SPCE | OSUR |
|---|---|---|
| Founded | 2017 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Transportation Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 207.3M | 214.1M |
| IPO Year | 2017 | 2000 |
| Metric | SPCE | OSUR |
|---|---|---|
| Price | $2.64 | $3.01 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 5 | 2 |
| Target Price | ★ $3.86 | $3.00 |
| AVG Volume (30 Days) | ★ 1.5M | 459.8K |
| Earning Date | 01-01-0001 | 05-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $7,036,000.00 | ★ $167,064,000.00 |
| Revenue This Year | N/A | $4.48 |
| Revenue Next Year | $2,528.09 | $7.76 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 3.47 | N/A |
| 52 Week Low | $2.18 | $2.08 |
| 52 Week High | $5.59 | $4.22 |
| Indicator | SPCE | OSUR |
|---|---|---|
| Relative Strength Index (RSI) | 51.31 | 51.90 |
| Support Level | $2.37 | $2.98 |
| Resistance Level | $2.67 | $3.12 |
| Average True Range (ATR) | 0.11 | 0.23 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 73.51 | 52.66 |
Virgin Galactic Holdings Inc is a United States-based vertically integrated aerospace company pioneering human spaceflight for private individuals & researchers, and it also manufactures air and space vehicles. Using technologies, the company is developing a spaceflight system designed to offer its customers a multi-day, and transformative experience. This culminates in a spaceflight that includes views of Earth from space and several minutes of weightlessness that will launch from Spaceport America, New Mexico.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.